Heregulin activation of ErbB2/ErbB3 signaling potentiates the integrity of airway epithelial barrier

Experimental Cell Research

Volumn 317, Issue 13, 2011, Pages 1947-1953

  Gon, Yasuhiro ^a   Matsumoto, Ken ^a   Terakado, Masahiro ^a   Sekiyama, Akiko ^a   Maruoka, Shuichiro ^a   Takeshita, Ikuko ^a   Kozu, Yutaka ^a   Okayama, Yoshimichi ^a   Ra, Chisei ^a   Hashimoto, Shu ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway epithelial cell; EGFR; ErbB3; Heregulin; Tight junction

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; NEU DIFFERENTIATION FACTOR; OCCLUDIN; PROTEIN ZO1; SMALL INTERFERING RNA;

AIRWAY; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DIMERIZATION; ELECTRIC RESISTANCE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MEMBRANE PERMEABILITY; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

EID: 79959331319     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.05.010     Document Type: Article

References (31)

1. Holgate S.T. Epithelium dysfunction in asthma. J. Allergy Clin. Immunol. 2007, 120:1233-1244. quiz 45-6.
2. Godfrey R.W., Severs N.J., Jeffery P.K. Structural alterations of airway epithelial tight junctions in cystic fibrosis: comparison of transplant and postmortem tissue. Am. J. Respir. Cell Mol. Biol. 1993, 9:148-156.
3. de Boer W.I., Sharma H.S., Baelemans S.M., Hoogsteden H.C., Lambrecht B.N., Braunstahl G.J. Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. Can. J. Physiol. Pharmacol. 2008, 86:105-112.
4. Tsukita S., Yamazaki Y., Katsuno T., Tamura A. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene 2008, 27:6930-6938.
5. Hossain Z., Hirata T. Molecular mechanism of intestinal permeability: interaction at tight junctions. Mol. Biosyst. 2008, 4:1181-1185.
6. Davies D.E., Polosa R., Puddicombe S.M., Richter A., Holgate S.T. The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma. Allergy 1999, 54:771-783.
7. Zeng F., Singh A.B., Harris R.C. The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp. Cell Res. 2009, 315:602-610.
8. Chang H., Riese D.J., Gilbert W., Stern D.F., McMahan U.J. Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature 1997, 387:509-512.
9. Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J., Park J.W., Yansura D., Abadi N., Raab H., Lewis G.D., Abadi N., Raab H., Lewis G.D., Shepard Mt, Kuang W.J., Wood W., Goeddel D.V., Vandlen Richard L. Identification of heregulin, a specific activator of p185erbB2. Science 1992, 256:1205-1210.
10. Yarden Y., Peles E. Biochemical analysis of the ligand for the neu oncogenic receptor. Biochemistry 1991, 30:3543-3550.
11. Mathia N.R., Timoszyk J., Stetsko P.I., Megill J.R., Smith R.L., Wall D.A. Permeability characteristics of calu-3 human bronchial epithelial cells: in vitro-in vivo correlation to predict lung absorption in rats. J. Drug Target. 2002, 10:31-40.
12. Forbes B., Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. Eur. J. Pharm. Biopharm. 2005, 60(2):193-205.
13. Geys J., Nemery B., Hoet P.H. Optimisation of culture conditions to develop an in vitro pulmonary permeability model. Toxicol. In Vitro 2007, 21(7):1215-1219.
14. Grainger C., Greenwell L.L., Lockley D.J., Martin G.P., Forbes B. Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier. Pharm. Res. 2006, 23(7):1482-1490.
15. Nerurkar M., Burton P., Borchardt R. The use of surfactants to enhance the permeability of peptides and proteins through Caco-2 cells by inhibition of an apically polarized efflux system. Pharm. Res. 1996, 13:528-534.
16. Cox D.S., Raje S., Gao H., Salama N.N., Eddington N.D. Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin. Pharm. Res. 2002, 19:1680-1688.
17. Carraway K.L., Cantley L.C. A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling. Cell 1994, 78:5-8.
18. Holbro T., Beerli R.R., Maurer F., Koziczak M., Barbas C.F., Hynes N.E. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation. Proc. Natl Acad. Sci. U. S. A. 2003, 100:8933-8938.
19. Kumar V.H., Lakshminrusimha S., El Abiad M.T., Chess P.R., Ryan R.M. Growth factors in lung development. Adv. Clin. Chem. 2005, 40:261-316.
20. Wells A. EGF receptor. Int. J. Biochem. Cell Biol. 1999, 31:637-643.
21. Alison M.R., Sarraf C.E. The role of growth factors in gastrointestinal cell proliferation. Cell Biol. Int. 1994, 18:1-10.
22. O'Donnell R.A., Frew A.J. Is there more than one inflammatory phenotype in asthma?. Thorax 2002, 57:566-568.
23. O'Donnell R.A., Richter A., Ward J., Angco G., Mehta A., Rousseau K., Swallow D.M., Holgate S.T., Djukanovic R., Davies D.E., Wilson S.J. Expression of ErbB receptors and mucins in the airways of long term current smokers. Thorax 2004, 59:1032-1040.
24. Polosa R., Puddicombe S.M., Krishna M.T., Tuck A.B., Howarth P.H., Holgate S.T., Davies D.E. Expression of c-erbB receptors and ligands in the bronchial epithelium of asthmatic subjects. J. Allergy Clin. Immunol. 2002, 109:75-81.
25. Sliwkowski M.X., Schaefer G., Akita R.W., Lofgren J.A., Fitzpatrick V.D., Nuijens A., Fendly B.M., Cerione R.A., Vandlen R.L., Carraway K.L. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 1994, 269:14661-14665.
26. Wallasch C., Weiss F.U., Niederfellner G., Jallal B., Issing W., Ullrich A. Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J. 1995, 14:4267-4275.
27. Horan T., Wen J., Arakawa T., Liu N., Brankow D., Hu S., Ratzkin B., Philo J.S. Binding of Neu differentiation factor with the extracellular domain of Her2 and Her3. J. Biol. Chem. 1995, 270:24604-24608.
28. Plowman G.D., Culouscou J.M., Whitney G.S., Green J.M., Carlton G.W., Foy L., Neubauer M.G., Shoyab M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl Acad. Sci. U. S. A. 1993, 90:1746-1750.
29. Carraway K.L., Sliwkowski M.X., Akita R., Platko J.V., Guy P.M., Nuijens A., Diamonti A.J., Vandlen R.L., Cantley L.C., Cerione R.A. The erbB3 gene product is a receptor for heregulin. J. Biol. Chem. 1994, 269:14303-14306.
30. Vermeer P.D., Panko L., Karp P., Lee J.H., Zabner J. Differentiation of human airway epithelia is dependent on erbB2. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 291:L175-L180.
31. Riethmacher D., Sonnenberg-Riethmacher E., Brinkmann V., Yamaai T., Lewin G.R., Birchmeier C. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 1997, 389:725-730.